Where Discovery Leads is a multimedia storytelling project that delves into key research themes at CHOP Research Institute. This is part one of a three-part series that focuses on novel diagnostic tools and approaches being developed under the leadership of the Center for Autism Research at CHOP. See part 2 and part 3 of the series.
Children’s Hospital of Philadelphia (CHOP) today joins with other research leaders in celebrating the U.S. Food and Drug Administration’s (FDA) approval of Spark Therapeutics’ innovative gene therapy for the treatment of a rare, inherited form of retinal blindness.
The end of the year has come up fast, and so have important advances in pediatric research at Children's Hospital of Philadelphia. This week's In the News starts off with a celebration of two remarkable patients and their dedicated pediatric oncologist.
August is perfect for lazy summer days, but our pediatric research news never rests. So whether you're lounging by the pool or relaxing in a shady hammock, pull up In the News to find out the science that is hot at The Children's Hospital of Philadelphia.
This week’s stories from The Children’s Hospital of Philadelphia include the use of big data to understand a tiny molecular mechanism central to how cells function, a clinical trial of video games for improving attention, and the neurodevelopmental effects of so-called “smart drugs.”
Alexander Fiks, MD, MSCE, a primary care pediatrician at The Children’s Hospital of Philadelphia, wears many hats, and he is adding one more with his recent appointment as director of the American Academy of Pediatrics’ Pediatric Research in Office Settings (PROS) network.
ADHD is the most common neurobehavioral disorder among children, occurring in about 8 percent of youth. Yet each child experiences symptoms of inattention, impulsivity, and hyperactivity differently, so delivering treatment that is responsive to individuals’ specific needs, goals, and family preferences can be time-consuming and complex.